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Abstract
Objective To build an in vitro-perfused, three-
dimensional (3D) spheroid model based on the
TissueFlex system for anti-cancer drug efficacy testing
in order to mimic avascular micro-tissues with inher-
ent O2, nutrient and metabolite gradients, and to
provide a more accurate prediction of drug toxicity
and efficacy than traditional in vitro tumour models in
conventional static culture well plates.
Results The perfused cancer spheroid model showed
higher cell viability and increased diameter of
spheroids over a relatively long culture period
(17 days). Three anti-cancer drugs with different
cytotoxic mechanisms were tested. In perfusion, lower
cytotoxicity was observed for traditional cytotoxic
drug 5-fluorouracil and microtubule-interfering, pacli-
taxel, showed greater interruption of spheroid integ-
rity. For the hypoxic-dependent drug, tirapazamine,
there was no significant difference observed between
static and perfusion cultures.
Conclusion The perfusion culture provides a better
homeostasis for cancer cell growth in a more control-
lable working platform for long-term drug testing.
Keywords Anti-cancer drugs  Cancer spheroids 
Drug screening  Perfusion  Three-dimensional cancer
model
Introduction
Three-dimensional (3D) cell-based in vitro models
using tissue engineering is an emerging but promising
technique for anti-cancer drug screening. Conven-
tional drug testing relies on results obtained from
animal-based in vivo tumour models, such as trans-
planting human cancer cells into immunodeficient
mice, which has a high cost, a long duration of
research and may give misleading results due to
intrinsic interspecies differences (Nyga et al. 2011).
To solve these problems, researchers have cultured
cancer cells isolated from humans in 3D environ-
ments, which are known as 3D in vitro models.
Compared with conventional cell-based in vitro mod-
els in two-dimensional (2D) monolayers, 3D in vitro
models mimic the in vivo interactions between cells
and the extracellular matrix (ECM) in studies on
proliferation, differentiation, and gene expression of
cancer cells (Bottaro et al. 2002).
Multicellular tumour spheroids (MCTS), which are
the aggregates formed by cancer cells, are a widely
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applied 3D in vitro model. This model has potential to
predict chemotherapy response profiles for clinical
practice (Elliott and Yuan 2011). Techniques to create
MCTS include liquid overlay, rotary vessel or spinner
flask and a more recently-developed polymeric aque-
ous two-phase system (Atefi et al. 2014). One
limitation of MCTS models is the limitation of
spheroid growth over a long culture time: without
blood perfusion, the passive diffusion of nutrient and
O2 into the spheroids becomes insufficient to maintain
the functions of the cells in the centre of the spheroids,
which then causes significant necrosis when the
spheroid diameter is [600 lm (Friedrich et al.
2009), and subsequently affects the accuracy of the
following testing (Inamdar and Borenstein 2011).
Here, we developed an in vitro 3D perfused cancer
spheroid model for anti-cancer drug testing by using
TissueFlex microbioreactors (Cui et al. 2007). MCTS
were cultured in perfusion over 17 days, with
increased growth limit compared to spheroids in
conventional static culture. Three anti-cancer drugs
with different mechanisms of action were tested to see
if our system can reflect their characteristics: 5-fluo-
rouracil is a pyrimidine analog interrupting cancer cell
DNA replication (Longley et al. 2003), tirapazamine is
activated to a toxic radical only in the hypoxic area of
cancer tissues (Tung and Hsiao et al. 2011), and
paclitaxel interferes with microtubule assembly in
actively proliferating cells (Zhou and Giannakakou
2005).
Methods and materials
Cell line culture and maintenance
The colorectal cancer cell line, DLD-1, and the breast
cancer cell line, NCI/ADR (ATCC), were cultured in
high-glucose Dulbecco’s Modified Eagle Medium
supplemented with 10 % (v/v) foetal bovine serum
and 100 U penicillin/ml and 100 lg streptomycin/ml
in a humidified incubator at 37 C with 5 % CO2.
TissueFlex microbioreactor production
and spheroid formation
Poly(dimethylsiloxane) (PDMS) polymers and
crosslinking reagent (Sylgard 184 silicone elastomer,
DowCorning) with the ratio of 10:1 were poured into a
designed mould and cross-linked at 60 C overnight.
The product TissueFlex (Zyoxyel Ltd, UK), a single
direction, multiple parallel perfused micro-bioreactor
system is shown in Fig. 1a below. The nutrient rich
culture media or tested anti-cancer drugs are individ-
ually perfused through inlet tubing by a syringe pump
(Harvard Apparatus, US) to the bioreactors, where 3D
micro-tissues are housed in the wells with the same
size of the wells of 96-well plates, and the nutrient
depleted medium is collected separately through the
outlet tubing.
The surface of PDMS was treated with 0.1 M
H2SO4 overnight at room temperature to make it
hydrophilic, allowing the ensuring addition of agarose
to form a concave surface. The wells were then rinsed
with sterile distilled water three times, and 1.5 % (w/
v) agarose was added to each well at 60 C, and then
allowed to solidify over 20 min at room temperature.
Cell suspensions with 5 9 102 to 3 9 103 cells were
added to each well, and the images of formed
spheroids were captured using an inverted microscope
(Nikon) and processed using software ImageJ (NIH,
USA). The diameters of ten spheroids were measured
and averaged for each group. Cells were seeded at 103
well. (This is described in more detail in the supple-
mentary information—Supplementary Fig. 1b).
Cell viability analysis
Cell viability was assessed by AlamarBlue assay
(Invitrogen) based on the manufacturer’s instructions.
Briefly, AlamarBlue solution was incubated in each
well for 2 h, then the fluorescence intensity at 560 nm
excitation and 590 nm emission was measured using a
micro-plate reader. Cell viability inhibition percent-
age = [(cell viability of untreated sample - cell
viability of sample treated by anti-cancer drug)/cell
viability of untreated sample] 9 100 %.
Cell live/dead imaging
A viability/cytotoxicity kit (Invitrogen) was used for
imaging the live and dead cells. The red fluorescent
ethidium homodimer-1 (EthD-1) only permeated
through and stained the dead cells, while living cells
allow the penetration of non-fluorescent acetomethoxy
derivative of calcein (calcein AM) and degrade it into
the green fluorescent calcein. The samples were
visualised using a multi-photon microscope (MPM)
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(Zeiss, Germany). All serial optical sections from
individual datasets were loaded into Imaris 7.6.1
(Bitplane Ag, Switzerland) software for processing
and analysis.
Perfusion and static culture
For perfusion culture, growth medium (DMEM with
10 % FBS), or DMEM containing drug or control
(0.1 % DMSO) was perfused continuously from day 4
to day 17 at 10 ll/h using a 10-channel syringe pump
(Harvard Apparatus, US). The same medium was
renewed in static and monolayer cultures every 3 days
from day 4 after seeding until day 17 (The cell seeding
day was counted as day 1.) 10 lM 5-fluorouracil (5-
FU) (Sigma), paclitaxel (Sigma) and tirapazamine
(TPZ) (Toronto Research Chemicals Inc.) was tested,
based on clinical drug dosage (Ando et al. 2008; Hong
Fig. 1 a (i) Schematic diagram of the bioreactor. The output is
collected in eppendorf tubes and the input is controlled by mini
syringe pumps. The well size is the same as those in normal
96-well plates. The transparent PDMS polymer allows the
spheroids growth to be monitored real-time under an inverted
microscope. (ii) Photo of the TissueFlex testing platform.
b Growth kinetics of the spheroids. (i) Representative images of
spheroids from Day 4 to Day 15. Scale bar 200 lm; (ii)
Spheroid growth curve; between Day 6 and Day 15, significantly
different diameters were observed between static and perfusion
spheroids. *p\ 0.05, **p\ 0.01 by Student’s t test. c Mul-
tiphoton microscope imaging for live/dead staining. (i) Sec-
tion imaging; (ii) 3D reconstruction of data set represented by
section imaging in Fig. 1c-(i). Scale bar 100 lm
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et al. 2011). Prior to drug exposure, spheroids were
cultured without perfusion for 3 days in TissueFlex
bioreactors or in 96-well plates (Friedrich et al. 2009).
Data analysis
The data has been presented as the mean ± the
standard error of the mean (SEM) of three independent
experiments (n = 3). Two-tailed Student’s t test with
*p\ 0.05 was regarded as significantly different.
Results and discussion
Kinetics of spheroids growth in static
and perfusion cultures
Figure 1b shows spheroids in both static and
perfusion cultures that were allowed to grow until
day 15. The average diameters of perfused spheroids
were significantly larger than statically cultured
spheroids from day 6 (at day 6 and 11, *p\ 0.05;
at day 8 and 15, **p\ 0.01 by Student’s t test). In
Fig. 1b, it is noticeable that the perfusion model
increased the growth potential of the spheroids as
shown by the spheroid diameter. At day 15 the
average diameter of the spheroids in static culture
reached 650 lm and had stopped growing. By
contrast, in perfusion culture, the perfused spheroids
reached an average diameter of 650 lm by day 12
and kept growing until the average diameter was
742 lm. A plateau in spheroid diameter was
observed after day 15 in both static and perfusion
cultures, and then the spheroid diameters decreased
on day 17. It is possible that on day 15, the
perfusion rate was not enough to provide nutrients
to all the cells inside the spheroids. The cells in
spheroids, especially in the central area of the
spheroids, suffered from deficiency of nutrients so
cells started to die and the number of viable cells
started decreasing.
The dimensions of spheroid cultures bring chal-
lenges to conventional confocal microscopy, whose
observable sample depth is *100 lm. Figure 1c
demonstrates how a multiphoton microscope (MPM)
can solve this limitation in imaging spheroids, con-
sidered previously to be 1 mm (Graf and Boppart
2010). Figure 1c shows at day 15 there were signif-
icant distributions of dead cells in the central areas of
spheroids in static culture, whereas only scattered dead
cells were observed within the spheroids in perfusion
culture. Figure 1c-ii is the 3D reconstruction image of
Fig. 1c-i using Imaris software. The dead cells (shown
in red) were observable in the static cultured spheroid,
while the spheroid cultured in perfusion only showed
scattered dead cells, revealed after the living cell areas
(green) were viewed as semi-transparent.
In long-term static culture of 3D in vitro models,
limited diffusion of nutrients causes dysfunction of
cell organelles, especially for some highly metaboli-
cally active cell types such as hepatocytes (LeCluyse
et al. 2012). The cumulated metabolites in medium
induce oxidative stress and lead to the rapid loss of cell
viability (Richert et al. 2006). In perfusion, O2 and
nutrient supply are improved via pumping fresh
medium into the system, and the tumour microenvi-
ronment homeostasis is maintained by removing
metabolites continuously. In addition, perfusion cul-
ture prevents additional stress from sequential med-
ium change and reduces the contamination risk (Wu
and Kuo 2011).
Anti-cancer drug testing
The results in Fig. 2a suggest that there is significant
morphological difference between static and perfused
drug treatment, especially in the case of paclitaxel—in
the static group there were still 3D structures remain-
ing in the centre of the well, while in the perfused
group the whole structure was nearly lost, with cell
aggregates scattered over the well. Comparison of cell
viability in Fig. 2b shows that after 72 h of 5-FU
treatment, the highest cell viability inhibition was
observed in the 2D monolayer model (35 %), and the
3D perfusion model showed the lowest drug response
(21.7 %). A significant difference was observed
between 2D and 3D perfusion cultures (p = 0.00706
by Student’s t test). 5-FUworks as a pyrimidine analog
to irreversibly inhibit thymidylate synthase and further
interferes with cancer cell DNA replication; the effects
of the drug clearly rely on it reaching the targeted cells
(Longley et al. 2003). The larger size of spheroids in
perfusion culture probably caused a lower drug
penetration efficiency, due to the increased barriers
for the drug penetration compared with 2D monolay-
ers of cells.
For the tirapazamine (TPZ)-treated spheroids, sig-
nificant drug inhibition was only observed in 3D
1392 Biotechnol Lett (2016) 38:1389–1395
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models, with 21.8 % in static culture and 23.7 % in
perfusion but there was no significant difference
between the two 3D models. Unlike the cytotoxicity
mechanism of 5-FU, the cytotoxicity of TPZ relies on
the hypoxic central area of 3D structures so it is
expected to have no effect in 2Dmonolayer cultures as
all the cells are exposed to the same level of O2 (Tung
and Hsiao et al. 2011).
Rather than killing cells directly like 5-FU, paclitaxel
acts on proliferating cells by interfering with micro-
tubule assembly. Microtubules are essential in tissue
structure formation and morphology maintenance
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Fig. 2 Drug testing
comparing static and
perfusion cultures.
a Representative images of
spheroids after 72 h of
treatment with different
drugs at the concentration of
10 lM. Note the significant
morphological difference
between static and perfused




concentration was 10 lM,
after 72 h of treatment. A
significant difference was
observed between 3D static
and perfusion testing of
paclitaxel (p = 0.00312 by
Student’s t test).
c Representative MPM
images of spheroids after
treatment with different
drugs. As shown in a and c,
the spheroids perfused with
paclitaxel totally lost the
spheroid structures after
72 h. Scale bar 100 lm
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(Zhou andGiannakakou 2005).As shown in Fig. 2a and
c, the spheroids statically treated by paclitaxel still had
some 3D structures, while the spheroids perfused with
paclitaxel totally lost the spheroid structures after 72 h
with only small cell aggregates scattered in thewell. The
cytotoxicity of paclitaxel was more significant
(p = 0.028 by Student’s t test) in 3D spheroids com-
pared with 2D culture (56.2 %), and a significant
difference (p = 0.00312 by Student’s t test) was
observed between the viability inhibition percentages
of spheroids in static (69.67 %) and perfusion cultures
(91.3 %) as shown in Fig. 2b. How perfusion can
enhance the cytotoxic effect of paclitaxel in spheroids
needs to be further studied although it is possible that
perfusion enhances the intercellular interactions and
facilitates the anti-mitosis effect of paclitaxel.
Conclusions
An in vitro 3D perfused spheroid model for anti-
cancer drug testing was established. Spheroids per-
fused in TissueFlex showed improved cell viability
and increased growth potential, compared with static
cultured spheroids over 17 days of culture. The
combination of multiphoton microscope imaging and
perfusion enables detailed imaging. Perfusion pro-
vided precise control of the drug testing environment
in a mid-throughput and parallel manner. In perfusion,
paclitaxel showed its cytotoxicity more significantly
compared with static culture, while 5-FU had less
efficacy in perfusion spheroids compared with stati-
cally cultured ones. Future work will focus on more
detailed study of spheroid functions and structures,
and a high-throughput screening system will be
developed on the basis of this work.
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